Abstract Objective: To assess clinicopathological characteristics of primary gastro-entero-pancreatic poorlydifferentiated neuroendocrine carcinomas (GEP-PDNECAs) and evaluate overall survival in patients treatedwith systemic platinum and etoposide therapy.Methods: A detailed retrospective review of…
Abstract Objectives— Using gene expression profiling on frozen primary pancreatic endocrine tumors (PETs), we discovered RUNX1T1 as a leading candidate progression gene. This study was designed (1) to validate the…
Editors: Aejaz Nasir, Domenico CoppolaPublisher: Springer-Verlag, New YorkLanguage: EnglishYear: 2016eBook ISBN: 978-1-4939-3426-3Hardcover ISBN: 978-1-4939-3424-9No. of pages: XIII, 543 The first edition of “Neuroendocrine Tumors: Review of Pathology, Molecular and Therapeutic…
Abstract A robust immunohistochemical (IHC) assay for VEGFR2 was developed to investigate its utility for patient tailoring in clinical trials. The sensitivity, specificity, and selectivity of the IHC assay were…
Abstract. Background: Palladin is a metastasis-associated gene regulating cell motility. The expression of palladin protein in pancreatic neuroendocrine tumors (PET) and carcinomas (PECA) is not known. Materials and Methods: A…
Abstract Background: Understanding the concept of resuscitation is extremely important in the professional life of all healthcare workers. By achieving the appropriate resuscitation knowledge and psychomotor skills, the efficacy of…